Uniformed Services University of the Health Sciences

Medicine & Life Sciences

1. Wounds and Injuries 100%
2. Military Personnel 50%
3. HIV 48%
4. HIV-1 43%
5. Military Health Services 41%
6. Infections 40%
7. Neoplasms 40%
8. Vaccines 39%
9. Therapeutics 38%
10. Prostatic Neoplasms 33%
11. Population 29%
12. Traumatic Brain Injury 25%
13. Afghanistan 24%
14. Coronavirus 24%
15. Breast Neoplasms 24%
16. Mortality 23%
17. Confidence Intervals 23%
18. T-Lymphocytes 23%
19. Extremities 23%
20. Cohort Studies 22%
21. Biomarkers 22%
22. Survival 22%
23. Genes 21%
24. Iraq 21%
25. Proteins 21%
26. Health 20%
27. Antibodies 20%
28. Pandemics 20%
29. Vaccination 20%
30. Resuscitation 19%
31. Incidence 19%
32. Amputation 19%
33. Delivery of Health Care 19%
34. Transplants 19%
35. Systematic Reviews 18%
36. Swine 18%
37. Proteomics 18%
38. HIV Infections 17%
39. Lower Extremity 17%
40. Malaria 17%
41. Diarrhea 17%
42. Heterotopic Ossification 17%
43. Surgeons 17%
44. Odds Ratio 17%
45. Hemorrhagic Shock 16%
46. SARS Virus 16%
47. Physicians 16%
48. Serum 16%
49. Guidelines 16%
50. Education 15%
51. Armed Conflicts 15%
52. Epidemiology 15%
53. Sepsis 15%
54. Safety 14%
55. Inflammation 14%
56. Nitric Oxide 14%
57. Critical Care 14%
58. Hemorrhage 14%
59. Kidney 13%
60. Anti-Bacterial Agents 13%
61. Post-Traumatic Stress Disorders 13%
62. Medicine 13%
63. Allografts 13%
64. Skin 13%
65. Pharmaceutical Preparations 13%
66. Veterans 13%
67. Blood Vessels 13%
68. Liver 12%
69. AIDS Vaccines 12%
70. Lung 12%
71. Genome 12%
72. Virus Diseases 12%
73. Communicable Diseases 12%
74. Child 12%
75. Hospital Emergency Service 12%
76. Viruses 11%
77. Primates 11%
78. Clinical Trials 11%
79. Balloon Occlusion 11%
80. Registries 11%
81. Pain 11%
82. Antibody Formation 11%
83. Disease Outbreaks 11%
84. Students 11%
85. Demography 11%
86. Equipment and Supplies 11%
87. Mutation 11%
88. Gene Expression 10%
89. Military Facilities 10%
90. Cytokines 10%
91. Antigens 10%
92. Muscles 10%
93. Dengue Virus 10%
94. Extracellular Matrix 10%
95. In Vitro Techniques 10%
96. Costs and Cost Analysis 10%
97. Randomized Controlled Trials 10%
98. Ovarian Neoplasms 10%
99. Meta-Analysis 10%
100. Growth 10%